Report ID: ARS1437 | Category: Healthcare | Pages: 107 | Format: PDF | Published Date: August 16,2023
Table of Content 1 Nuclear Medicine Diagnostics Market Overview 1.1 Nuclear Medicine Diagnostics Product Overview 1.1.1 Nuclear Medicine Diagnostics Product Scope 1.1.2 Nuclear Medicine Diagnostics Market Status and Outlook 1.2 Global Nuclear Medicine Diagnostics Market Size Overview by Region 2018 VS 2022VS 2029 1.3 Global Nuclear Medicine Diagnostics Market Size by Region (2018-2029) 1.4 Global Nuclear Medicine Diagnostics Historic Market Size by Region (2018-2023) 1.5 Global Nuclear Medicine Diagnostics Market Size Forecast by Region (2023-2029) 1.6 Key Regions, Nuclear Medicine Diagnostics Market Size (2018-2029) 1.6.1 North America Nuclear Medicine Diagnostics Market Size (2018-2029) 1.6.2 Europe Nuclear Medicine Diagnostics Market Size (2018-2029) 1.6.3 Asia-Pacific Nuclear Medicine Diagnostics Market Size (2018-2029) 1.6.4 Latin America Nuclear Medicine Diagnostics Market Size (2018-2029) 1.6.5 Middle East & Africa Nuclear Medicine Diagnostics Market Size (2018-2029) 2 Nuclear Medicine Diagnostics Market Overview by Type 2.3 Global Nuclear Medicine Diagnostics Market Size by Type: 2018 VS 2022 VS 2029 2.4 Global Nuclear Medicine Diagnostics Historic Market Size by Type (2018-2023) 2.5 Global Nuclear Medicine Diagnostics Forecasted Market Size by Type (2023-2029) 2.6 Key Regions Market Size Segment by Type (2018-2029) 2.6.1 North America Nuclear Medicine Diagnostics Market Size Breakdown by Type (2018-2029) 2.6.2 Europe Nuclear Medicine Diagnostics Market Size Breakdown by Type 2.6.3 Asia-Pacific Nuclear Medicine Diagnostics Market Size Breakdown by Type 2.6.4 Latin America Nuclear Medicine Diagnostics Market Size Breakdown by Type 2.6.5 Middle East and Africa Nuclear Medicine Diagnostics Market Size Breakdown by Type 3 Nuclear Medicine Diagnostics Market Overview by Application 3.3 Global Nuclear Medicine Diagnostics Market Size by Application: 2018 VS 2022 VS 2029 3.4 Global Nuclear Medicine Diagnostics Historic Market Size by Application (2018-2023) 3.5 Global Nuclear Medicine Diagnostics Forecasted Market Size by Application (2023-2029) 3.6 Key Regions Market Size Segment by Application (2018-2029) 3.6.1 North America Nuclear Medicine Diagnostics Market Size Breakdown by Application (2018-2029) 3.6.2 Europe Nuclear Medicine Diagnostics Market Size Breakdown by Application 3.6.3 Asia-Pacific Nuclear Medicine Diagnostics Market Size Breakdown by Application 3.6.4 Latin America Nuclear Medicine Diagnostics Market Size Breakdown by Application 3.6.5 Middle East and Africa Nuclear Medicine Diagnostics Market Size Breakdown by Application 4 Nuclear Medicine Diagnostics Competition Analysis by Players 4.1 Global Nuclear Medicine Diagnostics Market Size by Players (2018-2023) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine Diagnostics as of 2022) 4.3 Date of Key Players Enter into Nuclear Medicine Diagnostics Market 4.4 Global Top Players Nuclear Medicine Diagnostics Headquarters and Area Served 4.5 Key Players Nuclear Medicine Diagnostics Product Solution and Service 4.6 Competitive Status 4.6.1 Nuclear Medicine Diagnostics Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 North America Nuclear Medicine Diagnostics Market Segment by Country 5.1 North America Nuclear Medicine Diagnostics Market Size by Country (2018-2029) 5.2 United States 5.3 Canada 6 Europe Nuclear Medicine Diagnostics Market Segment by Country 6.1 Europe Nuclear Medicine Diagnostics Market Size by Country (2018-2029) 6.2 Germany 6.3 France 6.4 U.K. 6.5 Italy 6.6 Russia 6.7 Nordic 6.8 Rest of Europe 7 Asia-Pacific Nuclear Medicine Diagnostics Market Segment by Country 7.1 Asia-Pacific Nuclear Medicine Diagnostics Market Size by Region (2018-2029) 7.2 China 7.3 Japan 7.4 South Korea 7.5 Southeast Asia 7.6 India 7.7 Australia 7.8 Rest of Asia-Pacific 8 Latin America Nuclear Medicine Diagnostics Market Segment by Country 8.1 Latin America Nuclear Medicine Diagnostics Market Size by Country (2018-2029) 8.2 Mexico 8.3 Brazil 8.4 Rest of Latin America 9 Middle East and Africa Nuclear Medicine Diagnostics Market Segment by Country 9.1 Middle East & Africa Nuclear Medicine Diagnostics Market Size by Country (2018-2029) 9.2 Turkey 9.3 Saudi Arabia 9.4 UAE 9.5 Rest of Middle East & Africa 10 Manufacturers Profiles 10.1 Cardinal Health (U.S.) 10.1.1 Cardinal Health (U.S.) Information 10.1.2 Business Overview 10.1.3 Cardinal Health (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.1.4 Nuclear Medicine Diagnostics Products Offered 10.1.5 Cardinal Health (U.S.) Recent Development 10.2 General Electric (U.S.) 10.2.1 General Electric (U.S.) Information 10.2.2 Business Overview 10.2.3 General Electric (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.2.4 Nuclear Medicine Diagnostics Products Offered 10.2.5 General Electric (U.S.) Recent Development 10.3 Lantheus (U.S.) 10.3.1 Lantheus (U.S.) Information 10.3.2 Business Overview 10.3.3 Lantheus (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.3.4 Nuclear Medicine Diagnostics Products Offered 10.3.5 Lantheus (U.S.) Recent Development 10.4 Bayer AG (Germany) 10.4.1 Bayer AG (Germany) Information 10.4.2 Business Overview 10.4.3 Bayer AG (Germany) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.4.4 Nuclear Medicine Diagnostics Products Offered 10.4.5 Bayer AG (Germany) Recent Development 10.5 Bracco Diagnostic Inc. (Italy) 10.5.1 Bracco Diagnostic Inc. (Italy) Information 10.5.2 Business Overview 10.5.3 Bracco Diagnostic Inc. (Italy) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.5.4 Nuclear Medicine Diagnostics Products Offered 10.5.5 Bracco Diagnostic Inc. (Italy) Recent Development 10.6 NorthStar Medical Radioisotopes, LLC (U.S.) 10.6.1 NorthStar Medical Radioisotopes, LLC (U.S.) Information 10.6.2 Business Overview 10.6.3 NorthStar Medical Radioisotopes, LLC (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.6.4 Nuclear Medicine Diagnostics Products Offered 10.6.5 NorthStar Medical Radioisotopes, LLC (U.S.) Recent Development 10.7 Eckert & Ziegler. (Germany) 10.7.1 Eckert & Ziegler. (Germany) Information 10.7.2 Business Overview 10.7.3 Eckert & Ziegler. (Germany) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.7.4 Nuclear Medicine Diagnostics Products Offered 10.7.5 Eckert & Ziegler. (Germany) Recent Development 10.8 Jubilant DraxImage, Inc. (Canada) 10.8.1 Jubilant DraxImage, Inc. (Canada) Information 10.8.2 Business Overview 10.8.3 Jubilant DraxImage, Inc. (Canada) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.8.4 Nuclear Medicine Diagnostics Products Offered 10.8.5 Jubilant DraxImage, Inc. (Canada) Recent Development 10.9 PharmaLogic Holdings Corp. (U.S.) 10.9.1 PharmaLogic Holdings Corp. (U.S.) Information 10.9.2 Business Overview 10.9.3 PharmaLogic Holdings Corp. (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.9.4 Nuclear Medicine Diagnostics Products Offered 10.9.5 PharmaLogic Holdings Corp. (U.S.) Recent Development 10.10 Institute of Isotopes Co., Ltd (Hungary) 10.10.1 Institute of Isotopes Co., Ltd (Hungary) Information 10.10.2 Business Overview 10.10.3 Institute of Isotopes Co., Ltd (Hungary) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.10.4 Nuclear Medicine Diagnostics Products Offered 10.10.5 Institute of Isotopes Co., Ltd (Hungary) Recent Development 10.11 SHINE Medical Technologies, LLC (U.S.) 10.11.1 SHINE Medical Technologies, LLC (U.S.) Information 10.11.2 Business Overview 10.11.3 SHINE Medical Technologies, LLC (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.11.4 Nuclear Medicine Diagnostics Products Offered 10.11.5 SHINE Medical Technologies, LLC (U.S.) Recent Development 10.12 Global Medical Solutions LLC (China) 10.12.1 Global Medical Solutions LLC (China) Information 10.12.2 Business Overview 10.12.3 Global Medical Solutions LLC (China) Nuclear Medicine Diagnostics Revenue, Gross Margin 10.12.4 Nuclear Medicine Diagnostics Products Offered 10.12.5 Global Medical Solutions LLC (China) Recent Development 11 Nuclear Medicine Diagnostics Market Dynamics 11.1 Nuclear Medicine Diagnostics Industry Trends 11.2 Nuclear Medicine Diagnostics Growth Drivers 11.3 Nuclear Medicine Diagnostics Market Challenges 11.4 Nuclear Medicine Diagnostics Market Restraints 12 Research Findings and Conclusion 13 Methodology and Data Source 13.1 A Methodology 13.1.1 Research Process 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 B Data Source 13.2.1 Legal Disclaimer
It contains all the geographic trends, and market analysis for global market